Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Lilly's bowel disease drug gets US FDA nod for treatment in adults
posted:
Thu, 10/26/2023 - 19:12 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Eli Lilly's bowel disease drug gets US FDA's approval in adults
posted:
Thu, 10/26/2023 - 18:40 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Tenaya Therapeutics Gets FDA Clearance To Begin Clinical Testing Of TN-401 Gene Therapy
posted:
Thu, 10/26/2023 - 09:05 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Akebia Gets FDA Acceptance Of Resubmission To NDA Of Vadadustat For Treatment Of Anemia Due To CKD
posted:
Wed, 10/25/2023 - 08:49 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
FDA Approves New Therapy For Rare Blood Cancers
posted:
Wed, 10/25/2023 - 04:17 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
AstraZeneca : FDA Accepts For Review SBLA For Self-administration Of Flumist Quadrivalent
posted:
Tue, 10/24/2023 - 07:33 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
FDA Approves BioMarin Pharma's Voxzogo For Children Under 5 Years With Achondroplasia
posted:
Fri, 10/20/2023 - 21:36 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Pfizer Secures FDA Approval For Penbraya
posted:
Fri, 10/20/2023 - 16:24 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
U.S. FDA approves expanded use of BioMarin's therapy for type of dwarfism
posted:
Fri, 10/20/2023 - 16:20 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
US FDA approves Pfizer's vaccine for meningococcal diseases
posted:
Fri, 10/20/2023 - 15:39 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
FDA Grants Orphan Drug Designation For Sage Therapeutics' SAGE-718 To Treat Huntington's Disease
posted:
Wed, 10/18/2023 - 07:07 EDT
by:
Nasdaq News
#channels::
#All
,
#Business
,
#News
,
#Nasdaq
,
#NasdaqNews
,
#Stocks
Hyloris Pharma wins US FDA approval for pain treatment
posted:
Wed, 10/18/2023 - 01:00 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Aldeyra Therapeutics Falls After FDA Indicated Addl. Clinical Trial For Reproxalap For Dry Eye
posted:
Mon, 10/16/2023 - 10:18 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
AstraZeneca: TAGRISSO Plus Chemotherapy Granted Priority Review By FDA
posted:
Mon, 10/16/2023 - 07:13 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Catalyst Pharma Reports FDA Acceptance Of SNDA For FIRDAPSE
posted:
Fri, 10/13/2023 - 12:45 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Pagination
Previous page
‹‹
Page 11
Next page
››